TLR9 and hepatocellular carcinoma: Chen et al. reported that HCQ modulates autophagy and induces DNA damage in hepatocellular carcinoma, helping to overcome sorafenib resistance via the TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 axis [69].